DNA Methylation Profiling of Chronic Pain

慢性疼痛的 DNA 甲基化分析

• 批准号: 7869051
• 负责人: ANDREAS S. BEUTLER
• 金额: $ 19.83万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-02-16 至 2011-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7869051
• 关键词: DNA Methylation; chronic pain

DESCRIPTION (provided by applicant): DNA cytosine methylation is a keeper of "cellular memory", stable and able to (co-)determine gene expression. De novo cytosine methylation occurs in development and, if activated inappropriately in the adult, can cause disease. Chronic pain often arises without visible insult or persists after tissue injury has healed. In the rodent single nerve ligation (SNL) pain model, L4 and L5 dorsal root ganglion (DRG) neurons and glia become dysfunctional with altered electrophysiology, gene expression, and cellular plasticity. The basic molecular force underlying these alterations is unknown. Here we propose that chronic pain is reflected in - and possibly driven by - DNA cytosine methylation changes in dorsal root ganglion cells. We imply that cytosine methylation may constitute a new conceptual layer to be added to known pain mechanisms. The hypothesis of this proposal is that cytosine methylation in adult DRG neurons and/or glia is plastic; that it is altered by experimental nerve injury; that it (co-)determines gene expression patterns characteristic of the pain state; and that it is a cause of poor patient recovery from chronic pain. Our proposal has two aims. Aim 1: To test if cytosine methylation is globally altered in DRGs of neuropathic pain-rats. The HELP assay (=HpaII tiny fragment Enrichment by Ligation-mediated PCR) will be used to perform a genome-wide analysis of 1 million HpaII tiny fragments (HTF) reflecting the methylation status of ~1.4 million unique HpaII/MspI sites in the L4 and L5 DRGs harvested 14 days after SNL or sham operation. Analyses will identify genomic regions where cytosine methylation is altered and sets of individual loci and/or of large gene regulatory regions where methylation changes are most marked. Aim 2: To test if cytosine methylation is locally altered in predicted regulatory regions. 70 pain genes will be chosen from the literature and from HELP result for in-depth methylation analysis of every CpG around each transcription start site using MassArray, a method of methylation analysis combining base-specific cleavage and mass-spectrometry. Research outcomes of Aims 1 and 2 will be validated in an independent set of animals. If conducted now, the proposed study would be the first to investigate DNA cytosine methylation in pain. PUBLIC HEALTH RELEVANCE: Cytosine is one out of the four building blocks that make up DNA. Unlike the other three building blocks, cytosine can be permanently chemically modified through a process called DNA cytosine methylation. This process leads to "methyl-cytosine", which is often referred to as the "fifth base" of the genome. Methyl cytosine is a keeper of "cellular memory", stable and able to (co-)determine how genes function. De novo cytosine methylation occurs in development and, if activated inappropriately in the adult, can cause diseases like cancer. Chronic pain often arises without a clear cause and can persist after tissue injury has healed. In the rodent model, two small structures of the nervous system located near the spinal cord, the L4 and L5 dorsal root ganglion (DRG) become dysfunctional. The basic force underlying these alterations is unknown. Here we propose that chronic pain is reflected in - and possibly driven by - DNA cytosine methylation changes in dorsal root ganglion cells. We imply that cytosine methylation may constitute a new conceptual layer to be added to our current knowledge about how chronic pain arises. The hypothesis of this proposal is that cytosine methylation in adult DRG neurons and/or glia is plastic; that it is altered by experimental nerve injury; that it (co- )determines gene expression patterns characteristic of the pain state; and that it is a cause of poor patient recovery from chronic pain. Our proposal has two aims. Aim 1: To test if cytosine methylation is globally altered in DRGs of neuropathic pain-rats. We will answer this question using a new technology, which we have developed, the HELP assay. This method combines digestion of DNA, amplification, and binding to 2.1 million probes on a glass slide. It allows us to obtain a picture of cytosine methylation for the entire genome in a single experiment. Aim 2: To test if cytosine methylation is locally altered in predicted regulatory regions. 70 pain genes will be chosen from the literature and from HELP result for in-depth methylation analysis of every CpG around each transcription start site using another method termed MassArray, which has specific advanteages when results with high resolution are desired. Research outcomes of Aims 1 and 2 will be confirmed in an independent set of animals. If conducted now, the proposed study would be the first to investigate DNA cytosine methylation in pain.

描述（由申请人提供）：DNA胞嘧啶甲基化是“细胞记忆”的保持者，稳定并且能够（共同）决定基因表达。从头胞嘧啶甲基化发生在发育过程中，如果在成人中不适当地激活，可能会导致疾病。慢性疼痛通常在没有明显损伤的情况下出现，或者在组织损伤愈合后持续存在。在啮齿动物单神经结扎（SNL）疼痛模型中，L4和L5背根神经节（DRG）神经元和胶质细胞变得功能障碍，电生理学，基因表达和细胞可塑性改变。这些变化背后的基本分子力是未知的。在这里，我们提出，慢性疼痛反映在背根神经节细胞中的DNA胞嘧啶甲基化变化中，并可能由其驱动。我们暗示，胞嘧啶甲基化可能构成一个新的概念层被添加到已知的疼痛机制。该提议的假设是，成年DRG神经元和/或神经胶质细胞中的胞嘧啶甲基化是可塑性的;它被实验性神经损伤改变;它（共同）决定疼痛状态特征性的基因表达模式;并且它是患者从慢性疼痛中恢复不良的原因。我们的建议有两个目的。目的1：检测神经病理性疼痛大鼠背根节中胞嘧啶甲基化是否发生了全面改变。将使用HELP试验（=通过连接介导的PCR进行HpaII微小片段富集）对100万个HpaII微小片段（HTF）进行全基因组分析，反映SNL或假手术后14天采集的L4和L5 DRG中约140万个独特HpaII/MspI位点的甲基化状态。分析将确定胞嘧啶甲基化改变的基因组区域和甲基化变化最显著的单个基因座和/或大基因调控区域的集合。目的2：检测胞嘧啶甲基化是否在预测的调控区域局部改变。将从文献和HELP结果中选择70个疼痛基因，使用MassArray对每个转录起始位点周围的每个CpG进行深入甲基化分析，MassArray是一种结合碱基特异性切割和质谱的甲基化分析方法。目的1和2的研究结果将在一组独立的动物中进行验证。如果现在进行，这项研究将是第一个研究疼痛中DNA胞嘧啶甲基化的研究。 公共卫生相关性：胞嘧啶是构成DNA的四个基本成分之一。与其他三种构建模块不同，胞嘧啶可以通过称为DNA胞嘧啶甲基化的过程进行永久性化学修饰。这个过程导致“甲基胞嘧啶”，这通常被称为基因组的“第五个碱基”。甲基胞嘧啶是“细胞记忆”的保持者，稳定并且能够（共同）决定基因如何发挥作用。从头胞嘧啶甲基化发生在发育过程中，如果在成人中被不适当地激活，可能导致癌症等疾病。慢性疼痛通常在没有明确原因的情况下出现，并且在组织损伤愈合后可能持续存在。在啮齿动物模型中，位于脊髓附近的神经系统的两个小结构，L4和L5背根神经节（DRG）变得功能障碍。这些变化背后的基本力量是未知的。在这里，我们提出，慢性疼痛反映在背根神经节细胞中的DNA胞嘧啶甲基化变化中，并可能由其驱动。我们暗示，胞嘧啶甲基化可能构成一个新的概念层添加到我们目前的知识，慢性疼痛是如何产生的。该提议的假设是，成年DRG神经元和/或神经胶质细胞中的胞嘧啶甲基化是可塑性的;它被实验性神经损伤改变;它（共同）决定疼痛状态特征性的基因表达模式;并且它是患者从慢性疼痛中恢复不良的原因。我们的建议有两个目的。目的1：检测神经病理性疼痛大鼠背根节中胞嘧啶甲基化是否发生了全面改变。我们将使用我们开发的新技术HELP检测来回答这个问题。这种方法结合了DNA消化、扩增和结合载玻片上的210万个探针。它使我们能够在一个实验中获得整个基因组的胞嘧啶甲基化的图片。目的2：检测胞嘧啶甲基化是否在预测的调控区域局部改变。将从文献和HELP结果中选择70个疼痛基因，使用另一种称为MassArray的方法对每个转录起始位点周围的每个CpG进行深入甲基化分析，当需要高分辨率的结果时，MassArray具有特定的选择性。目的1和2的研究结果将在一组独立的动物中得到证实。如果现在进行，这项研究将是第一个研究疼痛中DNA胞嘧啶甲基化的研究。